Mitochondria alterations in fibroblasts from sporadic Alzheimer's disease (AD) patients correlate with AD-related clinical hallmarks
Eysert, F.; Kinoshita, P. F.; Lagarde, J.; Lacas-Gervais, S.; Xicota, L.; Dorothee, G.; Bottlaender, M.; Checler, F.; Potier, M.-C.; Sarazin, M.; Chami, M.
Show abstract
INTRODUCTIONMitochondria dysfunctions are key features in Alzheimers disease (AD). The occurrence of these disturbances in AD patients peripheral cells and their potential correlation with disease progression are under investigated. METHODSWe studied mitochondrial structure, function and mitophagy in fibroblasts including healthy volunteers and AD patients at the prodromal (AD-MCI) or demented (AD-D) stages. We carried out correlation studies with clinical cognitive scores, A{beta} plaques burden and the accumulation of peripheral amyloid precursor protein C-terminal fragments (APP-CTFs). RESULTSWe unveiled progressive alteration of mitochondria structure as well as specific mitochondrial dysfunctions signatures in AD-MCI and AD-D fibroblasts and show defective mitophagy and autophagy linked to impaired lysosomal activity in AD-D fibroblasts. We reported on significant correlations of a subset of these dysfunctions with cognitive decline, AD-related clinical hallmarks and peripheral APP-CTFs accumulation. DISCUSSIONThis study emphasizes the potential use of peripheral cells for investigating AD pathophysiology and likely diagnosis.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction, progression, and prion-like spread of Alzheimer s disease pathogenesis 96%
- TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer's disease hippocampus 96%
- C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimers disease 95%
Similar papers in this journal
- Regional interneuron transcriptional changes reveal pathologic markers of disease progression in a mouse model of Alzheimer's disease 95%
- Co-expression patterns of microglia markers Iba1, TMEM119 and P2RY12 in Alzheimer's disease 95%
- Immune receptor LAG3 regulates microglia function duringAlzheimer's disease 94%
Similar papers in this journal
- Low circulating choline, a modifiable dietary factor, is associated with the pathological progression and metabolome dysfunction in Alzheimers disease. 96%
- Early synaptic pathology is associated with small tau aggregates in Alzheimer's disease 96%
- Tau phosphorylated at serine 356 is associated with Alzheimer's disease pathology and can be lowered in mouse and human brain tissue using the NUAK inhibitor WZ4003 95%
Similar papers in this journal
- miR-519a-3p, found to regulate cellular prion protein during Alzheimer's disease pathogenesis, as a biomarker of asymptomatic stages 93%
- Dicer1 promotes Aβ clearance via blocking B2 RNA-mediated repression of apolipoprotein E 92%
- p21-activated kinase regulates Rab3a vesicles to repair plasma membrane damage caused by Amyloid-β oligomers 91%